REDOX Ltd FY26 Results Show Record $1.330b Revenue and 19% NPAT Growth

Redox FY26 full year results delivered record revenue of $1.330b, NPAT up 19.2% to $92m, and North American sales exceeding $100m for the first time — here's what investors need to know.
By Josua Ferreira -
  • Redox posted record sales revenue of $1.330b in FY26, up 6.9%, with statutory NPAT rising 19.2% to $92m — earnings growing nearly three times faster than revenue signals genuine operating leverage.
  • North American sales exceeded $100m for the first time, growing 33.8%, with the business now operating coast-to-coast across the US and recording its first Canadian wins.
  • Cash from operations nearly doubled from $48m to $88m, and Redox closed the year with $123m cash and zero net debt, providing capacity for further acquisitions without shareholder dilution.
  • The full-year dividend was lifted to 13 cents per share — up 4% on the prior year — with a payout ratio of 74%, sitting within the group's long-term 60–80% target range.
  • Gross margin expanded 0.8 percentage points to 22.4%, supported by improved product mix in Asia-Pacific and a strengthening North American margin profile, while after-tax ROIC improved to 14.6%.
Summarise with AI:

Redox reports record $1.330b revenue in FY26 results presentation

In its FY26 full-year results presentation delivered on 20 August 2026, Redox (RDX.ASX) reported record sales revenue of $1.330b, an increase of 6.9% on the prior corresponding period (PCP). The chemical distribution group also posted statutory net profit after tax (NPAT) of $92m, up 19.2%, and lifted its full-year dividend to 13 cps.

Chief Executive Officer and Managing Director Raimond Coneliano and Chief Financial Officer Kim Yap presented the results, outlining a year of organic growth supplemented by acquisition contribution, delivered against a backdrop of subdued demand. Management framed FY26 as a period of margin improvement, strengthening cash generation and a debt-free balance sheet.

FY26 headline results at a glance

The results presentation set out a scorecard of gains across every headline line item.

  • Sales Revenue: $1.330b (+6.9%)
  • Gross Profit: $298m (+11.0%); Gross Margin 22.4% (+0.8ppts)
  • EBITDAFX: $134m (+9.9%)
  • NPAT (statutory): $92m (+19.2%)
  • After-tax ROIC: 14.6% (+1.1ppts)
  • Basic EPS: 17.5 cps (+19.2%)
  • Final Dividend: 6.5 cps, payout ratio 74%

The profit and loss overview compares FY26 with the prior year across key underlying metrics.

FY26 vs FY25 Key Financial Metrics Comparison

Metric FY26 $m FY25 $m Change
Revenue 1,330 1,244 6.9%
Gross profit 298 269 11.0%
Gross margin 22.4% 21.6% 0.8ppts
Underlying EBITDAFX 134 122 9.9%
Underlying NPATFX 87 80 9.0%
Proforma EPS (cents) 17.5 14.7 19.2%
ROIC 14.6% 13.5% 1.1ppts

Growth was recorded across the board, with gross margin lifting on an improved product mix in the Asia-Pacific region and a strengthening margin profile in North America.

North American breakout and segment performance

The standout growth story came from North America, where sales grew 33.8% to exceed $100m for the first time. Management attributed the expansion to several factors.

  1. Customer conversions and share-of-wallet wins across the Industrial, Food, Human Health and Personal Care segments

  2. 47 new Active Products added to the portfolio

  3. Growth in the recently established US Southeast region, alongside first success in the Canadian market, extending the group’s US presence to “coast to coast”

Australian sales grew 6.1% to $1.120b, supported by the integration of acquired business Molekulis onto the Redebiz system. The acquisition added sales of Transformer Oil to transformer manufacturers, energy generators and transmission businesses. The completion of Redox’s acquisition of Molekulis Pty Ltd and Molekulis Limited occurred on 30 April 2025.

New Zealand revenue softened, declining 4.0% to $100m, impacted by lower demand from the Human Health industry segment.

What chemical distribution is and why the model matters

Redox describes itself as a globally significant chemical distributor, connecting suppliers and customers across a diverse range of industries.

The presentation detailed the scale of the platform underpinning this model:

  • 8,700+ active customers
  • 5,500+ SKUs
  • 1,200+ active suppliers
  • 100+ stock locations
  • 1,200+ product groups
  • 494-strong team

Management characterised the sector as highly attractive due to its fragmented structure, its essential role in global supply chains, and significant opportunities for organic growth and consolidation. Diversification across industries and geographies sits at the centre of the group’s resilience, reflected in a 30-year revenue CAGR of 10.1%.

Financial strength: cash generation and a debt-free balance sheet

The results presentation emphasised improved cash conversion and balance sheet quality. Cash from operations rose to $88m, up from $48m in the prior year, while free cash flow conversion improved by 21.8ppts to 62.5%, sitting within the long-term historical range of 60–80%.

Key balance sheet measures included:

  • Cash from operations: $88m (up from $48m)
  • Free cash flow conversion: 62.5% (+21.8ppts)
  • Cash & cash equivalents: $123m with zero net debt (including $70m invested in short-term deposit)
  • Net working capital as a % of revenue: 31.4% (improved, within long-term range)

CFO Commentary

The presentation noted that cash and cash equivalents of $123m, with zero net debt, provides abundant capacity to grow strongly, both organically and by acquisition.

The debt-free position gives Redox capacity to pursue both organic growth and acquisition opportunities.

Dividend lifted to 13 cps for the year

The presentation confirmed a continued focus on shareholder returns, with the dividend rising on the back of higher earnings.

  • Final FY26 dividend: 6.5 cps
  • Full-year dividend: 13 cps (up 4% on PCP)
  • Payout ratio: 74% of profits (long-term target 60–80%)
  • Payment date: 22 September 2026; record date 26 August 2026

The growing dividend is supported by rising earnings and remains within the group’s long-term payout ratio target.

Strategy and outlook: organic growth first

Management outlined a strategy built around four pillars from the Redox operating model: geographical expansion and M&A, diversification and resilience, strong purchasing power, and a leading sales force. The presentation reinforced that the primary focus is organic growth, complemented by acquisitions and geographic expansion.

Business growth and operations are supported by the group’s internally developed CRM/ERP system, Redebiz. Redox highlighted its extensive and growing customer, supplier and product base as a key competitive asset.

On outlook, management noted that performance is influenced by economic conditions, customer demand, product mix, supply chain developments and the timing of new business and acquisitions. Redox positioned itself as well placed to continue growing, supported by strong commercial teams, proprietary systems, a robust balance sheet and a diversified business model.

The presentation closed by reiterating that the chemical distribution sector remains highly attractive, with its fragmented structure and essential role in global supply chains offering ongoing opportunities for organic growth and consolidation.

Stay Ahead on ASX Industrials and Chemical Sector News

Get FREE breaking ASX announcements delivered to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ subscribers who never miss a market-moving update. Click the “Free Alerts” button at StockWire X to start receiving alerts the moment news breaks.


Frequently Asked Questions

What were Redox's FY26 full year results?

Redox reported record sales revenue of $1.330b for FY26, up 6.9% on the prior year, with statutory NPAT of $92m (up 19.2%), basic EPS of 17.5 cents, and a full-year dividend of 13 cents per share.

How did Redox's North American business perform in FY26?

Redox's North American sales grew 33.8% to exceed $100m for the first time, driven by new customer wins, 47 new active products, expansion into the US Southeast region, and first success in the Canadian market.

What is Redox's dividend for FY26 and when is it paid?

Redox declared a final dividend of 6.5 cents per share, bringing the full-year FY26 dividend to 13 cents per share — a 4% increase on the prior year — with a payment date of 22 September 2026 and a record date of 26 August 2026.

Does Redox have debt on its balance sheet?

Redox reported zero net debt as at FY26, with cash and cash equivalents of $123m including $70m invested in short-term deposits, giving the company significant capacity for organic growth and acquisitions.

What does Redox do as a business?

Redox is a chemical distributor that connects chemical suppliers and customers across a diverse range of industries, operating with over 8,700 active customers, 5,500+ SKUs, and 1,200+ active suppliers across Australia, New Zealand, and North America.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher